Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Biometals ; 19(5): 555-64, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16937262

ABSTRACT

The toxic milk (tx) mouse is a rodent model for Wilson disease, an inherited disorder of copper overload. Here we assessed the effect of copper accumulation in the tx mouse on zinc and iron metabolism. Copper, zinc and iron concentrations were determined in the liver, kidney, spleen and brain of control and copper-loaded animals by atomic absorption spectroscopy. Copper concentration increased dramatically in the liver, and was also significantly higher in the spleen, kidney and brain of control tx mice in the first few months of life compared with normal DL mice. Hepatic zinc was increased with age in the tx mouse, but zinc concentrations in the other organs were normal. Liver and kidney iron concentrations were significantly lower at birth in tx mice, but increased quickly to be comparable with control mice by 2 months of age. Iron concentration in the spleen was significantly higher in tx mice, but was lower in 5 day old tx pups. Copper-loading studies showed that normal DL mice ingesting 300 mg/l copper in their diet for 3 months maintained normal liver, kidney and brain copper, zinc and iron levels. Copper-loading of tx mice did not increase the already high liver copper concentrations, but spleen and brain copper concentrations were increased. Despite a significant elevation of copper in the brain of the copper-loaded tx mice no behavioural changes were observed. The livers of copper-loaded tx mice had a lower zinc concentration than control tx mice, whilst the kidney had double the concentration of iron suggesting that there was increased erythrocyte hemolysis in the copper-loaded mutants.


Subject(s)
Copper/metabolism , Hepatolenticular Degeneration/metabolism , Iron/metabolism , Mice, Inbred Strains , Zinc/metabolism , Animals , Ceruloplasmin/metabolism , Female , Homeostasis , Humans , Liver/cytology , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred BALB C , Time Factors , Tissue Distribution
2.
Genomics ; 88(3): 309-15, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16631345

ABSTRACT

Hemoglobin E (HbE) is caused by a G-->A mutation at codon 26 of the beta-globin gene, which substitutes Glu-->Lys. This mutation gives rise to functional but unstable hemoglobin and activates a cryptic splice site causing mild anemia. HbE reaches a carrier frequency of 60-80% in some Southeast Asian populations. HbE causes serious disease when co-inherited with a beta-thalassemia mutation. In this study, we report the creation and evaluation of humanized transgenic mice containing the beta(E) mutation in the context of the human beta-globin locus. Developmental expression of the human beta(E) locus transgene partially complements the hematological abnormalities in heterozygous knockout mice ((mu)beta(th-3/+)) and rescues the embryonic lethality of homozygous knockout mice ((mu)beta(th-3/th-3)). The phenotype of rescued mice was dependent on the transgene copy number. This mouse model displays hematological abnormalities similar to HbE/beta-thalassemia patients and represent an ideal in vivo model system for pathophysiological studies and evaluation of novel therapies.


Subject(s)
Gene Dosage , Hemoglobin E/genetics , Point Mutation , Transgenes , beta-Thalassemia/genetics , Animals , Disease Models, Animal , Humans , Mice , Mice, Transgenic , Phenotype , beta-Thalassemia/pathology , beta-Thalassemia/therapy
3.
Mamm Genome ; 16(4): 228-41, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15965784

ABSTRACT

Friedreich ataxia is an autosomal recessive neurodegenerative disorder caused by a GAA trinucleotide expansion in the first intron of the Friedreich ataxia gene (FRDA) that causes reduced synthesis of frataxin, a mitochondrial protein likely to be involved in biosynthesis of iron-sulfur clusters. This leads to increased oxidative stress, progressive loss of large sensory neurons, and hypertrophic cardiomyopathy. To elucidate the mechanisms regulating FRDA expression and to develop an in vivo assay for agents that might upregulate FRDA expression in a therapeutically relevant manner, we have generated transgenic mice with a BAC genomic reporter construct consisting of an in-frame fusion between FRDA and the gene coding for enhanced green fluorescent protein (EGFP). Production of full-length frataxin-EGFP fusion protein was demonstrated by immunoblotting. EGFP expression was observed as early as day E3.5 of development. Most tissues of adult transgenic mice were fluorescent. The level of FRDA-EGFP expression in peripheral blood, bone marrow, and cells obtained from enzymatically disaggregated tissues was quantitated by flow cytometry. There was a twofold increase in EGFP expression in mice homozygous for the transgene when compared to hemizygous mice. These transgenic mice are a valuable tool for the examination of spatial and temporal aspects of FRDA gene expression and for the preclinical evaluation of pharmacological inducers of FRDA expression in a whole-animal model. In addition, tissues from these mice should also be valuable for stem cell transplantation studies.


Subject(s)
Disease Models, Animal , Friedreich Ataxia/genetics , Gene Expression Regulation, Developmental , Green Fluorescent Proteins/metabolism , Iron-Binding Proteins/genetics , Animals , Chromosomes, Artificial, Bacterial , Evaluation Studies as Topic , Flow Cytometry , Green Fluorescent Proteins/genetics , Immunoblotting , In Situ Hybridization, Fluorescence , Iron-Binding Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Transgenes/genetics , Frataxin
4.
Genomics ; 85(4): 453-61, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15780748

ABSTRACT

Accurate animal models that recapitulate the phenotype and genotype of patients with beta-thalassemia would enable the development of a range of possible therapeutic approaches. Here we report the generation of a mouse model carrying the codons 41-42 (-TTCT) beta-thalassemia mutation in the intact human beta-globin locus. This mutation accounts for approximately 40% of beta-thalassemia mutations in southern China and Thailand. We demonstrate a low level of production of gamma-globins from the mutant locus in day 18 embryos, as well as production of mutant human beta-globin mRNA. However, in contrast to transgenic mice carrying the normal human beta-globin locus, 4-bp deletion mice fail to show any phenotypic complementation of the knockout mutation of both murine beta-globin genes. Our studies suggest that this is a valuable model for gene correction in hemopoietic stem cells and for studying the effects of HbF inducers in vivo in a "humanized" thalassemic environment.


Subject(s)
Disease Models, Animal , Globins/genetics , Mice/genetics , Sequence Deletion , beta-Thalassemia/genetics , Animals , Embryo, Mammalian/abnormalities , Erythrocytes, Abnormal/cytology , Gene Expression , Globins/analysis , Globins/metabolism , Humans , Mice, Knockout , Phenotype , Transgenes
5.
J Gastroenterol Hepatol ; 19(11): 1283-90, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15482536

ABSTRACT

BACKGROUND AND AIM: The toxic milk (tx) mouse is a non-fatal animal model for the metabolic liver disorder, Wilson's disease. The tx mouse has a mutated gene for a copper-transporting protein, causing early copper accumulation in the liver and late accumulation in other tissues. The present study investigated the efficacy of liver cell transplantation (LCT) to correct the tx mouse phenotype. METHODS: Congenic hepatocytes were isolated and intrasplenically transplanted into 3-4-month-old tx mice, which were then placed on various copper-loaded diets to examine its influence on repopulation by transplanted cells. The control animals were age-matched untransplanted tx mice. Liver repopulation was determined by comparisons of restriction fragment length polymorphism ratios (DNA and mRNA), and copper levels were measured by atomic absorption spectroscopy. RESULTS: Repopulation in recipient tx mice was detected in 11 of 25 animals (44%) at 4 months after LCT. Dietary copper loading (whether given before or after LCT, or both) provided no growth advantage for donor cells, with similar repopulation incidences in all copper treatment groups. Overall, liver copper levels were significantly lower in repopulated animals (538 +/- 68 microg/g, n = 11) compared to non-repopulated animals (866 +/- 62 microg/g, n = 14) and untreated controls (910 +/- 103 microg/g, n = 6; P < 0.05). This effect was also seen in the kidney and spleen. Brain copper levels remained unchanged. CONCLUSION: Transplanted liver cells can proliferate and correct a non-fatal metabolic liver disease, with some restoration of hepatic copper homeostasis after 4 months leading to reduced copper levels in the liver and extrahepatic tissues, but not in the brain.


Subject(s)
Hepatocytes/physiology , Hepatocytes/transplantation , Hepatolenticular Degeneration/surgery , Liver/metabolism , Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/metabolism , Animals , Brain/metabolism , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Cell Proliferation , Copper/metabolism , Copper-Transporting ATPases , Disease Models, Animal , Hepatolenticular Degeneration/metabolism , Kidney/metabolism , Male , Mice , Mice, Congenic , RNA, Messenger/metabolism , Spleen/metabolism , Spleen/surgery
6.
Mamm Genome ; 15(5): 370-82, 2004 May.
Article in English | MEDLINE | ID: mdl-15170226

ABSTRACT

Three independent transgenic mouse lines were generated with the human Friedreich ataxia gene, FRDA, in an 188-kb bacterial artificial chromosome (BAC) genomic sequence. Three copies of the transgene per diploid mouse genome were integrated in a single site in each mouse line. Transgenic mice were mated with mice heterozygous for a knockout mutation of the murine Frda gene, to generate mice homozygous for the Frda knockout mutation and hemizygous or homozygous for the human transgene. Rescue of the embryonic lethality that is associated with homozygosity for the Frda knockout mutation was observed in all three lines. Rescued mice displayed normal behavioral and biochemical parameters. RT-PCR analysis demonstrated that human FRDA mRNA is expressed in all the lines. The relative expression of the human FRDA and mouse Frda genes showed a similar pattern in different tissues in all three lines, indicating position-independent control of expression of the human FRDA transgene. However, large differences in the human:mouse mRNA ratio were observed between different tissues in all three lines. The human transgene is expressed at much higher levels in the brain, liver, and skeletal muscle than the endogenous gene, while expression of the human transgene in blood is only 25-30% of the mouse gene. These studies will facilitate the development of humanized mouse models of Friedreich ataxia through introduction of a GAA trinucleotide expansion or specific known point mutations in the normal human FRDA locus and the study of the regulation of gene expression from the FRDA locus.


Subject(s)
Chromosomes, Artificial, Bacterial , Friedreich Ataxia/genetics , Friedreich Ataxia/physiopathology , Mice, Knockout/genetics , Mice, Transgenic/genetics , Mutation/genetics , Animals , Female , Gene Dosage , Genes, Lethal , Genetic Complementation Test , Homozygote , Humans , In Situ Hybridization, Fluorescence , Locomotion , Male , Mice , Phenotype , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Transgenes/physiology
7.
J Biol Chem ; 278(52): 52909-13, 2003 Dec 26.
Article in English | MEDLINE | ID: mdl-14555645

ABSTRACT

Methylmalonic aciduria is a human autosomal recessive disorder of organic acid metabolism resulting from a functional defect in the activity of the enzyme methylmalonyl-CoA mutase. Based upon the homology of the human mutase locus with the mouse locus, we have chosen to disrupt the mouse mutase locus within the critical CoA binding domain using gene-targeting techniques to create a mouse model of methylmalonic aciduria. The phenotype of homozygous knock-out mice (mut-/-) is one of early neonatal lethality. Mice appear phenotypically normal at birth and are indistinguishable from littermates. By 15 h of age, they develop reduced movement and suckle less. This is followed by the development of abnormal breathing, and all of the mice with a null phenotype die by 24 h of age. Urinary levels of methylmalonic and methylcitric acids are grossly increased. Measurement of acylcarnitines in blood shows elevation of propionylcarnitine with no change in the levels of acetylcarnitine and free carnitine. Incorporation of [14C]propionate in primary fibroblast cultures from mut-/- mice is reduced to approximately 6% of normal level, whereas there is no detectable synthesis of mut mRNA in the liver. This is the first mouse model that recapitulates the key phenotypic features of mut0 methylmalonic aciduria.


Subject(s)
Alkyl and Aryl Transferases/genetics , Carnitine/analogs & derivatives , Methylmalonyl-CoA Mutase/genetics , Amino Acid Metabolism, Inborn Errors , Animals , Blotting, Southern , Carnitine/chemistry , Carnitine/metabolism , Cell Line , Citrates/chemistry , DNA/metabolism , Fibroblasts/metabolism , Genotype , Homozygote , Liver/metabolism , Methylmalonic Acid/metabolism , Methylmalonyl-CoA Mutase/metabolism , Mice , Mice, Knockout , Mice, Transgenic , Models, Genetic , Phenotype , Plasmids/metabolism , Protein Structure, Tertiary , RNA, Messenger/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...